Japanese National Hospitals To Double Generic Drug Use In Five Years
This article was originally published in PharmAsia News
Executive Summary
Japan's national hospital systems will double current generic drug use in five years, according to a new policy that took effect April 1. The move aims to curtail growing medical costs by promoting generic drugs in large national and public hospitals. It also aims to change patient indifference to generic drugs. As of 2007, generic drug use accounted for 16 percent of total drugs used in the 145-hospital system; the new policy aims to increase that ratio to 30 percent by 2013. The new measure will mainly target inpatients as outpatients have their prescriptions filled elsewhere. (Click here for more - Japanese language
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.